Cargando…
Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway
BACKGROUND: A growing body of evidence has proven that long noncoding ribonucleic acids (lncRNAs) are important epigenetic regulators that play crucial parts in the pathogenesis of human cancers. Previous studies have shown that long intergenic nonprotein coding RNA 01116 (LINC01116) is a carcinogen...
Autores principales: | Shang, Bin, Li, Zhenxiang, Li, Meng, Jiang, Shujuan, Feng, Zhen, Cao, Zhixin, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287011/ https://www.ncbi.nlm.nih.gov/pubmed/34061456 http://dx.doi.org/10.1111/1759-7714.14042 |
Ejemplares similares
-
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020) -
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023) -
Promising Advances in LINC01116 Related to Cancer
por: Xu, Yating, et al.
Publicado: (2021) -
Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1
por: Chen, Zhifeng, et al.
Publicado: (2019) -
Silencing of LINC01116 Suppresses the Development of Oral Squamous Cell Carcinoma by up-Regulating microRNA-136 to Inhibit FN1 [Retraction]
Publicado: (2022)